Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;51(4):1194-1196.
doi: 10.1007/s00259-023-06479-8. Epub 2023 Oct 28.

The value of [18F]FET PET and somatostatin receptor imaging for differentiating pseudoprogression in residual meningioma

Katharina J Müller  1 , Annamaria Biczok  2 , Christian Schichor  2 , Louisa von Baumgarten  2 , Nathalie L Albert  3
Affiliations

The value of [18F]FET PET and somatostatin receptor imaging for differentiating pseudoprogression in residual meningioma

Katharina J Müller et al. Eur J Nucl Med Mol Imaging. 2024 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. JNS. 2015;122(1):4–23. doi: 10.3171/2014.7.JNS131644. - DOI - PMC - PubMed
    1. Ilhan H, Lindner S, Todica A, et al. Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2020;47(4):870–880. doi: 10.1007/s00259-019-04501-6. - DOI - PubMed
    1. Wirsching HG, Steiner L, Becker D, et al. Increase in contrast-enhancing volume of irradiated meningiomas reflects tumor progression and not pseudoprogression. Neuro Oncol. 2021;23(9):1612–1613. doi: 10.1093/neuonc/noab119. - DOI - PMC - PubMed
    1. Hennrich U, Benešová M. [68Ga]Ga-DOTA-TOC: the first FDA-approved 68Ga-radiopharmaceutical for PET imaging. Pharmaceuticals. 2020;13(3):38. doi: 10.3390/ph13030038. - DOI - PMC - PubMed
    1. Unterrainer M, Kunte SC, Unterrainer LM, et al. Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE. Eur J Nucl Med Mol Imaging. 2023;50:3390–3399. doi: 10.1007/s00259-023-06315-z. - DOI - PMC - PubMed